IIREF:OTC-iShares Public Limited Company - iShares MSCI World UCITS ETF (USD)

ETF | Others |

Last Closing

USD 77.075

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CSTNL iShares VII Public Limited Com..

N/A

USD 32.85B
ZKBGF ZKB Gold ETF

N/A

USD 8.96B
TOETF Tosei Corporation

N/A

USD 7.70B
EFMSF ETFS Metal Securities Limited ..

N/A

USD 7.39B
ETHE Grayscale Ethereum Trust (ETH)

N/A

USD 4.36B
EBCRY EBCRY

N/A

USD 3.42B
SSEEF SSgA SPDR ETFs Europe I Public..

N/A

USD 2.95B
IFXAF iShares Asia Trust - iShares F..

N/A

USD 2.94B
ZKBHF ZKB Gold ETF

N/A

USD 2.93B
GDRPF Golden Resources Development I..

N/A

USD 2.70B

ETFs Containing IIREF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.43% 68% D+ 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.43% 68% D+ 64% D
Trailing 12 Months  
Capital Gain 26.56% 73% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.56% 73% C 69% C-
Trailing 5 Years  
Capital Gain 64.76% 71% C- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 64.76% 71% C- 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 11.73% N/A N/A 56% F
Dividend Return 12.04% N/A N/A 53% F
Total Return 0.32% N/A N/A 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 17.83% N/A N/A 89% A-
Risk Adjusted Return 67.54% N/A N/A 93% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike